Omega-3 supplementation can shorten hospital stay for post-op gastrointestinal cancer patients: Review

By Cheryl Tay contact

- Last updated on GMT

The incidence of infectious complications was significantly different between the omega-3 and control groups. ©iStock
The incidence of infectious complications was significantly different between the omega-3 and control groups. ©iStock

Related tags: Omega-3 fatty acid, Nutrition, Fatty acid

Parenteral omega-3 fatty acid supplementation can benefit gastrointestinal cancer patients after operations, according to researchers in China.

Reseachers at China's Shandong University conducted a review to determine the effects of parenteral nutrition with omega-3 supplementation on immune function and clinical outcomes in post-operative gastrointestinal cancer patients.

They assessed seven RCTs involving a total of 457 participants. Of the seven trials, five (involving 373 participants) "indicated that the incidence of infectious complications was significantly different between the (omega-3) intervention and control groups"​.

In addition, five trials involving 385 participants showed that parenteral omega-3 fatty acid supplementation significantly reduced the duration of hospitalisation for post-operative gastrointestinal cancer patients.

The researchers also said omega-3 might be able to affect inflammatory response outcome — possibly through "leukocyte–endothelial interactions by oxidised omega-3 fatty acids" ​— and the production of inflammatory mediators.

Critical illness limitations

However, they stated there was insufficient evidence that parenteral nutrition with omega-3 supplementation had any significant impact on mortality, infectious complications, and duration of ICU stay for critically ill patients.

They said the review had found parenteral omega-3 supplementation beneficial to post-operative gastrointestinal cancer patients in terms of immune function and clinical outcomes, adding that these findings may be able to support the clinical application of omega-3 fatty acid supplementation.

They concluded: "However, these partial results should be treated with caution because of the limitations of and potential risk of bias in the included studies.

"Large-scale, randomised, prospective trials are warranted to assess the effect of parenteral omega-3 fatty acid supplementation in postoperative gastrointestinal cancer patients."

 

Source: Asia Pacific Journal of Clinical Nutrition

https://doi.org/10.6133/apjcn.022017.19

"Effects of parenteral ω-3 fatty acid supplementation in postoperative gastrointestinal cancer on immune function and length of hospital stay: a systematic review and meta-analysis"

Authors: Hao Bai, et al.

Related news

Show more

Related products

show more

HRB are ideal probiotics for human health

HRB are ideal probiotics for human health

Morinaga Milk Industry Co., Ltd. | 01-Nov-2019 | Technical / White Paper

Evidence is accumulated that the physiological benefits of probiotics bifidobacteria are not only strain-specific but also dependent on their residential...

Robuvit®: Award Winning Extract for Sport & Energy

Robuvit®: Award Winning Extract for Sport & Energy

Horphag Research | 20-Sep-2019 | Research Study

Newly launched Robuvit® French oak extract is a caffeine-free natural energizer that provides support for managing fatigue and improving sports performance....

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars

Nutra Champions Podcast

Nutra Champions Podcast